BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 25135958)

  • 1. RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas.
    Bao ZS; Chen HM; Yang MY; Zhang CB; Yu K; Ye WL; Hu BQ; Yan W; Zhang W; Akers J; Ramakrishnan V; Li J; Carter B; Liu YW; Hu HM; Wang Z; Li MY; Yao K; Qiu XG; Kang CS; You YP; Fan XL; Song WS; Li RQ; Su XD; Chen CC; Jiang T
    Genome Res; 2014 Nov; 24(11):1765-73. PubMed ID: 25135958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour exosomes from cells harbouring PTPRZ1-MET fusion contribute to a malignant phenotype and temozolomide chemoresistance in glioblastoma.
    Zeng AL; Yan W; Liu YW; Wang Z; Hu Q; Nie E; Zhou X; Li R; Wang XF; Jiang T; You YP
    Oncogene; 2017 Sep; 36(38):5369-5381. PubMed ID: 28504721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-sensitive clinical diagnostic method for PTPRZ1-MET and the characteristic protein structure contributing to ligand-independent MET activation.
    Huang R; Liu Y; Wang K; Wang Z; Zhang C; Zhang W; Zhao Z; Li G; Huang L; Chang Y; Zeng F; Jiang T; Hu H
    CNS Neurosci Ther; 2021 May; 27(5):617-628. PubMed ID: 33645009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced expression and phosphorylation of the MET oncoprotein by glioma-specific PTPRZ1-MET fusions.
    Chen HM; Yu K; Tang XY; Bao ZS; Jiang T; Fan XL; Chen XW; Su XD
    FEBS Lett; 2015 Jun; 589(13):1437-43. PubMed ID: 25935522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioblastomas harboring gene fusions detected by next-generation sequencing.
    Woo HY; Na K; Yoo J; Chang JH; Park YN; Shim HS; Kim SH
    Brain Tumor Pathol; 2020 Oct; 37(4):136-144. PubMed ID: 32761533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel PTPRZ1-ETV1 fusion in gliomas.
    Matjašič A; Zupan A; Boštjančič E; Pižem J; Popović M; Kolenc D
    Brain Pathol; 2020 Mar; 30(2):226-234. PubMed ID: 31381204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor.
    Hu H; Mu Q; Bao Z; Chen Y; Liu Y; Chen J; Wang K; Wang Z; Nam Y; Jiang B; Sa JK; Cho HJ; Her NG; Zhang C; Zhao Z; Zhang Y; Zeng F; Wu F; Kang X; Liu Y; Qian Z; Wang Z; Huang R; Wang Q; Zhang W; Qiu X; Li W; Nam DH; Fan X; Wang J; Jiang T
    Cell; 2018 Nov; 175(6):1665-1678.e18. PubMed ID: 30343896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma.
    Di Stefano AL; Fucci A; Frattini V; Labussiere M; Mokhtari K; Zoppoli P; Marie Y; Bruno A; Boisselier B; Giry M; Savatovsky J; Touat M; Belaid H; Kamoun A; Idbaih A; Houillier C; Luo FR; Soria JC; Tabernero J; Eoli M; Paterra R; Yip S; Petrecca K; Chan JA; Finocchiaro G; Lasorella A; Sanson M; Iavarone A
    Clin Cancer Res; 2015 Jul; 21(14):3307-17. PubMed ID: 25609060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent PTPRZ1-MET fusion and a high occurrence rate of MET exon 14 skipping in brain metastases.
    Chai RC; Liu X; Pang B; Liu YQ; Li JJ; Li YF; Zhao Z; Du J; Bao ZS; Jiang T
    Cancer Sci; 2022 Feb; 113(2):796-801. PubMed ID: 34812554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low c-Met expression levels are prognostic for and predict the benefits of temozolomide chemotherapy in malignant gliomas.
    Li MY; Yang P; Liu YW; Zhang CB; Wang KY; Wang YY; Yao K; Zhang W; Qiu XG; Li WB; Peng XX; Wang YZ; Jiang T
    Sci Rep; 2016 Feb; 6():21141. PubMed ID: 26879272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent MET fusion genes represent a drug target in pediatric glioblastoma.
    International Cancer Genome Consortium PedBrain Tumor Project
    Nat Med; 2016 Nov; 22(11):1314-1320. PubMed ID: 27748748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma.
    Parker BC; Annala MJ; Cogdell DE; Granberg KJ; Sun Y; Ji P; Li X; Gumin J; Zheng H; Hu L; Yli-Harja O; Haapasalo H; Visakorpi T; Liu X; Liu CG; Sawaya R; Fuller GN; Chen K; Lang FF; Nykter M; Zhang W
    J Clin Invest; 2013 Feb; 123(2):855-65. PubMed ID: 23298836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O6-methylguanine DNA methyltransferase gene promoter methylation status in gliomas and its correlation with other molecular alterations: first Indian report with review of challenges for use in customized treatment.
    Jha P; Suri V; Jain A; Sharma MC; Pathak P; Jha P; Srivastava A; Suri A; Gupta D; Chosdol K; Chattopadhyay P; Sarkar C
    Neurosurgery; 2010 Dec; 67(6):1681-91. PubMed ID: 21107199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the absolute value of O(6)-methylguanine-DNA methyltransferase gene messenger RNA a prognostic factor, and does it predict the results of treatment of glioblastoma with temozolomide?
    Tanaka S; Akimoto J; Narita Y; Oka H; Tashiro T
    J Neurosurg; 2014 Oct; 121(4):818-26. PubMed ID: 25105699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting gene fusions in glioma.
    Kim PL
    Curr Opin Neurol; 2021 Dec; 34(6):840-847. PubMed ID: 34766555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copy Number Profiling of Brazilian Astrocytomas.
    Bidinotto LT; Torrieri R; Mackay A; Almeida GC; Viana-Pereira M; Cruvinel-Carloni A; Spina ML; Campanella NC; Pereira de Menezes W; Clara CA; Becker AP; Jones C; Reis RM
    G3 (Bethesda); 2016 Jul; 6(7):1867-78. PubMed ID: 27172220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive protein tyrosine phosphatase mRNA profiling identifies new regulators in the progression of glioma.
    Bourgonje AM; Verrijp K; Schepens JT; Navis AC; Piepers JA; Palmen CB; van den Eijnden M; Hooft van Huijsduijnen R; Wesseling P; Leenders WP; Hendriks WJ
    Acta Neuropathol Commun; 2016 Sep; 4(1):96. PubMed ID: 27586084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic Fusions in Gliomas: An Institutional Experience.
    Polivka J; Svajdler M; Priban V; Mracek J; Kasik P; Martinek P; Ptakova N; Sharif Bagheri M; Shetti D; Pesta M; Potuznik P; Topolcan O
    Anticancer Res; 2022 Apr; 42(4):1933-1939. PubMed ID: 35347013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling predicts response to temozolomide in malignant gliomas.
    Yoshino A; Ogino A; Yachi K; Ohta T; Fukushima T; Watanabe T; Katayama Y; Okamoto Y; Naruse N; Sano E; Tsumoto K
    Int J Oncol; 2010 Jun; 36(6):1367-77. PubMed ID: 20428759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Fn14 in gliomas: tumor progression and poor prognosis.
    Tan D; Pang FM; Li D; Zhang L; Wu J; Liu ZQ; Li X; Yan H
    Future Oncol; 2018 Jun; 14(13):1273-1284. PubMed ID: 29741404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.